Daniel Morgensztern, MD

Daniel Morgensztern, MD

Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology, Section of Medical Oncology, Washington University School of Medicine

Clinical Expertise

Lung cancer

Research Interest

Main clinical and translational research interests are in the development of new Phase II clinical studies for patients with lung cancer.

Education

  • 1995: MD, Fundação Técnico-Educational Souza Marques, Rio de Janeiro, Brazil

Training

  • 1996 - 1998: Resident, internal medicine and hematology, State University of Rio de Janeiro, Brazil
  • 1998 - 2001: Resident, internal medicine, University of Miami-Jackson Memorial Hospital
  • 2001 - 2004: Fellow, hematology and oncology, University of Miami-Jackson Memorial Hospital

Board Certification

  • 2001: American Board of Internal Medicine, Internal Medicine
  • 2004: American Board of Internal Medicine, Medical Oncology

Selected Research Publications

Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  • Ettinger DS, Wood DE, Stevenson J, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2023
Trends in Stage I Lung Cancer.
  • Singareddy A, Flanagan ME, Samson PP, [...] Morgensztern D
  • Clin Lung Cancer 2023
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  • Ettinger DS, Wood DE, Aisner DL, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2022
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
  • Govindan R, Aggarwal C, Antonia SJ, [...] Morgensztern D, [...] Herbst RS
  • J Immunother Cancer 2022
Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.
  • Devarakonda S, Li Y, Martins Rodrigues F, [...] Morgensztern D, [...] Govindan R
  • J Clin Oncol 2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC.
  • Hann CL, Burns TF, Dowlati A, Morgensztern D, [...] Camidge DR
  • J Thorac Oncol 2021
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.
  • Lim KH, Opyrchal M, Acharya A, [...] Morgensztern D, [...] Wang-Gillam A
  • Eur J Cancer 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
  • Owonikoko TK, Park K, Govindan R, [...] Morgensztern D, [...] Kim HR
  • J Clin Oncol 2021
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
  • Ettinger DS, Wood DE, Aisner DL, [...] Morgensztern D, [...] Hughes M
  • J Natl Compr Canc Netw 2021

Contact Information

  • South St. Louis County

    5225 Midamerica Plaza
    St. Louis, MO 63129

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

Phone Numbers

Request an appointment